Seal anchor with non-parallel lumens

Information

  • Patent Grant
  • 10532168
  • Patent Number
    10,532,168
  • Date Filed
    Thursday, August 17, 2017
    7 years ago
  • Date Issued
    Tuesday, January 14, 2020
    4 years ago
Abstract
A seal anchor member defines a housing defining a longitudinal axis, the housing having leading and trailing ends, and including a plurality of lumens extending between the leading and trailing ends, each lumen being adapted for substantially sealed reception of an object therein and defining a longitudinal axis, wherein at least two of the lumens define longitudinal axes that are intersecting. The seal anchor member may be formed from a compressible material.
Description
BACKGROUND

1. Technical Field


The present disclosure relates to a seal for use in a surgical procedure. More particularly, the present disclosure relates to a seal anchor member adapted for insertion into an incision in tissue and including a plurality of non-parallel lumens adapted for the sealed reception of one or more surgical objects such that a substantially fluid-tight seal is formed with both the tissue and the surgical object or objects.


2. Background of the Related Art


Today, many surgical procedures are performed through small incisions in the skin, as compared to the larger incisions typically required in traditional procedures, in an effort to reduce both trauma to the patient and recovery time. Generally, such procedures are referred to as “endoscopic”, unless performed on the patient's abdomen, in which case the procedure is referred to as “laparoscopic”. Throughout the present disclosure, the term “minimally invasive” should be understood to encompass both endoscopic and laparoscopic procedures.


During a typical minimally invasive procedure, surgical objects, such as surgical access devices (e.g., trocar and cannula assemblies) or endoscopes, are inserted into the patient's body through the incision in tissue. In general, prior to the introduction of the surgical object into the patient's body, insufflation gasses are used to enlarge the area surrounding the target surgical site to create a larger, more accessible work area. Accordingly, the maintenance of a substantially fluid-tight seal is desirable so as to prevent the escape of the insufflation gases and the deflation or collapse of the enlarged surgical site.


To this end, various valves and seals are used during the course of minimally invasive procedures and are widely known in the art. However, a continuing need exists for a seal anchor member that can be inserted directly into the incision in tissue and that can accommodate a variety of surgical objects while maintaining the integrity of an insufflated workspace.


SUMMARY

Disclosed herein is a seal anchor including a housing defining a longitudinal axis, the housing having leading and trailing ends, and a plurality of lumens extending between the leading and trailing ends, each lumen being adapted for substantially sealed reception of an object therein and defining a longitudinal axis, wherein at least two of the lumens define longitudinal axes that are intersecting.


The leading end may include a recess adapted to stabilize instrumentation inserted into at least one of the lumens. The recess may be extend radially outward from the at least one lumen. Alternatively, the leading end may include a generally arcuate cutout. At least one of the lumens may be disposed within the generally arcuate cutout. The generally arcuate cutout may be adapted to stabilize instrumentation inserted into at least one of the lumens.


Furthermore, the housing of the seal anchor may be adapted to transition between a first compressed condition to facilitate at least partial insertion of the seal anchor member within a tissue tract, and a second expanded condition to facilitate securing of the seal anchor member within the tissue tract and in substantial sealed relation with tissue surfaces defining the tissue tract. In an embodiment, the housing may be formed from a compressible material or from a foam material. In an embodiment, the foam material may be at least partially constituted of a material selected from the group consisting of polyisoprene, urethane, and silicone. In another embodiment, the housing may be formed from a gel material.


In addition, the leading and trailing ends of the housing may include a substantially annular positioning member to facilitate anchoring of the seal anchor within a tissue tract. The housing may also define a substantially arcuate configuration. The housing may define a substantially hour glass shape. Furthermore, the lumens may define openings at the leading end that are radially spaced apart about the trailing end. Alternatively, the lumens may define openings at the leading end that are spaced along a diameter of the trailing end. The openings defined by the lumens may be staggered about an axis of the trailing end or may be positioned along a diameter but offset from that diameter. Alternatively, the openings defined by the lumens may be positioned on a chord or a diameter of the trailing end.


These and other features of the apparatus disclosed herein will become more readily apparent to those skilled in the art from the following detailed description of various embodiments of the present disclosure.





BRIEF DESCRIPTION OF THE DRAWINGS

Various embodiments of the present disclosure are described hereinbelow with references to the drawings, wherein:



FIG. 1 is a front perspective view of a seal anchor in accordance with the present disclosure shown relative to tissue;



FIG. 2A is a front perspective view of a seal anchor member having lumens therein that are parallel to one another;



FIG. 2B is a front perspective view of the seal anchor of FIG. 1 shown with medical instruments inserted therein;



FIG. 3 is another embodiment of a seal anchor in accordance with the present disclosure; and



FIG. 4 is a yet another embodiment of a seal anchor in accordance with the present disclosure.





DETAILED DESCRIPTION OF THE EMBODIMENTS

In the drawings and in the description which follows, in which like references numerals identify similar or identical elements, the term “proximal” will refer to the end of the apparatus which is closest to the clinician during use, while the term “distal” will refer to the end which is furthest from the clinician, as is traditional and known in the art. A seal anchor for use in a surgical procedure is shown and described in U.S. Pat. Pub. 2009-0093752, the entire contents of which is hereby incorporated by reference. The seal anchor member may be used during a minimally invasive procedure in which the seal anchor is inserted into an incision. Alternatively, the seal anchor may be used through a naturally occurring opening (e.g., anus or vagina) or any incision in a patient's skin.


A seal anchor 100 will now be described with reference to FIGS. 1 and 2. The seal anchor 100 defines a longitudinal axis “A” and has respective trailing (or proximal) and leading (or distal) ends 102, 104 and an intermediate portion 106 disposed between the trailing and leading ends 102, 104. Seal anchor member 100 includes one or more lumens (or ports) 108a, 108b, 108c disposed between the trailing and leading ends 102, 104 that define corresponding longitudinal axes “X”, “Y”, “Z”. As seen in FIG. 1, the axes “X”, “Y”, “Z” defined by the lumens 108a, 108b, 108c, respectively, are intersecting, i.e., are not parallel with one another. In contrast to seal anchor 100, a seal anchor 90 having parallel, non-intersecting lumens 98 is illustrated in FIG. 2A.


As seen in FIG. 2B, the lumens 108a-c are adapted to receive instrumentation therein in a substantially sealed manner. The lumens 108a-c are adapted to inhibit the escape of insufflation gasses within a body cavity with or without instrumentation being inserted therein. Accordingly, the lumens 108a-c have diameters that are adapted to contract in the absence of a surgical instrument inserted therein and are adapted to expand to accommodate instrumentation in a substantially sealed manner.


As shown in FIG. 2B, the instrumentation inserted within the lumens 108 may include, but are not limited to, a camera 20 that may be inserted within one of the lumens 108 and a pair of surgical instruments 21 that are inserted into two of the other lumens 108. Since the axes “X” and “Z” of the two lumens 108a, 108c, through which the pair of surgical instruments 21 are inserted, cross one another, the distance between the distal ends of the surgical instruments 21 is greater than it would be if the axes “X”, “Z” were parallel to one another. Since the lumens 108a, 108c define intersecting, i.e., non-parallel, axes, manipulation of the surgical instruments 21 is facilitated since there is a lesser probability of the instruments 21 interfering with each other's use.


As previously discussed, FIG. 2A illustrates a seal anchor 90 including lumens 98 that are parallel to one another. Inserted within lumens 98 are surgical instruments 21 and camera 20. As seen in FIG. 2A, the parallel configuration of the lumens 98 hinder camera 20 in obtaining a clear view of the surgical site. It will be appreciated that the non-parallel, intersecting configuration of the lumens 108a-c of seal anchor 100 facilitate obtaining a lesser obstructed field of view than would be obtainable using seal anchor 90. In particular, as shown in FIG. 2B, axes “X” and “Z” define an angle “θ” therebetween. The greater the value of angle “θ”, the lesser the probability of surgical instruments 21 obstructing the view of camera 20. Moreover, the greater the angle “θ”, the lesser the probability of interference between instruments 21 during the procedure. In addition, the greater the angle “θ”, the greater the number of internal structures included within the surgical field and within reach of instruments 21.


Proximal end 102 of seal anchor member defines a first diameter D1 and distal end 104 defines a second diameter D2. In one embodiment of seal anchor member 100, the respective first and second diameters D1, D2 of the proximal and distal ends 102, 104 are substantially equivalent, as seen in FIG. 1, although an embodiment of seal anchor member 100 in which diameters D1, D2 are different is also within the scope of the present disclosure. As depicted in FIG. 1, proximal and distal ends 102, 104 define substantially planar surfaces. However, embodiments are also contemplated herein in which either or both of proximal and distal ends 102, 104, respectively, define surfaces that are substantially arcuate to assist in the insertion of seal anchor member 100 within a tissue tract 12 defined by tissue surfaces 14 and formed in tissue “T”, e.g., an incision, as discussed in further detail below.


Intermediate portion 106 defines a radial dimension “R” and extends longitudinally between proximal and distal ends 102, 104, respectively, to define an axial dimension or length “L”. The radial dimension “R” of intermediate portion 106 varies along the axial dimension, or length, “L” thereof. Accordingly, seal anchor member 100 defines a cross-sectional dimension that varies along its length “L”, which facilitates the anchoring of seal anchor member 100 within tissue “T”, as discussed in further detail below. However, an embodiment of seal anchor member 100 in which the radial dimension “R” remains substantially uniform along the axial dimension “L” thereof is also within the scope of the present disclosure.


The radial dimension “R” of intermediate portion 106 is appreciably less than the respective diameters D1, D2 of proximal and distal ends 102, 104 such that seal anchor member 100 defines an “hour-glass” shape or configuration to assist in anchoring seal anchor member 100 within tissue “T”, as discussed in further detail below. However, in an alternate embodiment, the radial dimension “R” of intermediate portion 106 may be substantially equivalent to the respective diameters D1, D2 of proximal and distal ends 102, 104. In cross section, intermediate portion 106 may exhibit any suitable configuration, e.g., substantially circular, oval or oblong.


The seal anchor 100 may be adapted to transition from an expanded condition to a compressed condition so as to facilitate the insertion and securement thereof within tissue tract 12 in tissue “T”. In the expanded condition, seal anchor 100 is at rest and the respective radial dimensions D1, D2 of the proximal and distal ends 102, 104 of seal anchor 100, as well as the radial dimension R of the intermediate portion 106 are such that the seal anchor 100 cannot be inserted within tissue tract 12. However, the seal anchor 100 may transition to a compressed condition such that proximal and distal ends 102, 104, as well as intermediate portion 106 are dimensioned for insertion into tissue tract 12.


To facilitate the transition between an expanded and a compressed condition, the seal anchor 100 may be formed from a compressible material having an internal biasing force such that the seal anchor 100 will transition back to an expanded condition upon insertion of the seal anchor 100 within tissue tract 12, thereby ensuring a seal between the seal anchor 100 and the tissue tract 12. Seal anchor 100 may be formed from a shape memory material, a foam material, or a gel material, or the like, but may also be formed from other materials. In an embodiment, the seal anchor 100 may be formed from a material selected from the group consisting of polyisoprene, urethane, and silicone.


Positioning members 114, 115 of the trailing and leading ends 102, 104, respectively, may engage the walls defining the body cavity of the tissue tract 12 to facilitate securement of seal anchor member 100 within the body tissue. For example, positioning member 114 at leading end 104 may engage the internal peritoneal wall and positioning member 114 adjacent trailing end 102 may engage the outer epidermal tissue adjacent the incision 12 within tissue “T”. In another embodiment of seal anchor member 100, one or more additional positioning members 114 may be associated with intermediate portion 106.


The use and function of seal anchor member 100 will be discussed during the course of a typical minimally invasive procedure. Initially, the peritoneal cavity (not shown) is insufflated with a suitable biocompatible gas such as, e.g., CO2 gas, such that the cavity wall is raised and lifted away from the internal organs and tissue housed therein, providing greater access thereto. The insufflation may be performed with an insufflation needle or similar device, as is conventional in the art. Either prior or subsequent to insufflation, a tissue tract 12 is created in tissue “T”, the dimensions of which may be varied dependent upon the nature of the procedure.


Different embodiments of seal anchors will be described with reference to FIGS. 2 and 3. Seal anchors 200, 300 are substantially similar to seal anchor 100, except in the configuration of lumens and further include structures to stabilize instrumentation inserted within the lumens. Both seal anchor 200 and seal anchor 300, shown in FIGS. 2 and 3, include lumens defining intersecting axes. Seal anchor 200 includes a trailing end 202 and a distal end 204. A plurality of lumens 208 is disposed between the trailing and leading ends 202, 204. Lumens 208 define openings in the trailing end 202 that are radially positioned along the trailing end 202. A cut-out or groove 201 in the leading end extending outward from at least one lumen 208 facilitates stabilization of instrumentation inserted within the lumen 208.


In an alternative embodiment, a seal anchor 300 including plurality of lumens disposed between leading and trailing ends 302, 304 is shown in FIG. 4. A cut-out or groove 301 in an arcuate or half-cylindrical configuration is disposed in the trailing end. At least one lumen 308 is disposed within the groove 301. Groove 301 is adapted to facilitate stabilization of instrumentation inserted within the at least one of the lumens 308 that is disposed within the area defined by the groove 301.


Although the illustrative embodiments of the present disclosure have been described herein with reference to the accompanying drawings, the above description, disclosure, and figures should not be construed as limiting, but merely as exemplifications of particular embodiments. It is to be understood, therefore, that the disclosure is not limited to those precise embodiments, and that various other changes and modifications may be effected therein by one skilled in the art without departing from the scope or spirit of the disclosure.

Claims
  • 1. A surgical device comprising: a housing formed of a compressible foam material and having a longitudinal axis, the housing having a proximal end, a distal end, and an intermediate portion, the intermediate portion having a radial dimension that varies along the longitudinal axis of the housing to facilitate anchoring of the device in tissue;the housing defining two or more lumens extending between the proximal and distal ends, the two or more lumens being non-parallel with respect to the longitudinal axis of the housing, the two or more lumens crossing one another without intersecting, and the two or more lumens being adapted to receive surgical instrumentation therethrough, the two or more lumens having diameters that contract in the absence of the surgical instrumentation and being adapted to expand to accommodate the surgical instrumentation in a sealed manner, wherein the distal end of the housing defines a groove in a half-cylindrical configuration, a depth of the groove varying along a length of the housing such that a center portion of the groove has a first depth and a lateral portion of the groove has a second depth less than the first depth.
  • 2. The device according to claim 1, wherein the two or more lumens of the housing includes three lumens.
  • 3. The device according to claim 1, wherein the housing includes an insertion feature insertion feature disposed in the proximal end of the housing.
  • 4. The device according to claim 1, wherein the proximal end of the housing and the distal end of the housing are arranged to engage walls defining a body cavity of a tissue tract.
  • 5. The device according to claim 1, wherein the compressible foam material is selected from the group consisting of polyisoprene, urethane, and silicone.
  • 6. A surgical device comprising: a housing formed of a compressible material and defining a longitudinal axis, the housing having a proximal end, a distal end, and an intermediate portion, the intermediate portion having a dimension that varies along the longitudinal axis of the housing;the housing defining two or more lumens extending between the proximal and distal ends, each lumen of the two or more lumens defining an acute angle with respect to the longitudinal axis of the housing, the two or more lumens being adapted to receive surgical instrumentation in a sealed manner, wherein the distal end of the housing defines a groove in a half-cylindrical configuration such that a depth of the groove varies along the longitudinal axis of the housing such that a center portion of the groove defining concavity has a first depth and a lateral portion of the groove has a second depth less than the first depth.
  • 7. The device according to claim 6, wherein the proximal and distal ends of the housing are configured to engage an opening in tissue.
  • 8. The device according to claim 6, wherein the housing is formed of a foam material.
  • 9. The device according to claim 8, wherein the foam material of the housing is selected from the group consisting of polyisoprene, urethane, and silicone.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 14/573,673, filed Dec. 17, 2014, which is a continuation of U.S. patent application Ser. No. 14/248,520 filed Apr. 9, 2014, now U.S. Pat. No. 9,017,250, which is a continuation of U.S. patent application Ser. No. 14/248,534, filed Apr. 9, 2014, now U.S. Pat. No. 8,932,213, which is a continuation of U.S. patent application Ser. No. 13/891,717 filed May 10, 2013, now abandoned, which is a continuation of U.S. patent application Ser. No. 12/887,847 filed Sep. 22, 2010, now U.S. Pat. No. 8,932,212, which claims benefit of U.S. Provisional Application No. 61/247,654 filed Oct. 1, 2009, and the disclosures of each of the above-identified applications are hereby incorporated by reference in their entirety.

US Referenced Citations (262)
Number Name Date Kind
4016884 Kwan-Gett Apr 1977 A
4112932 Chiulli Sep 1978 A
4183357 Bentley et al. Jan 1980 A
4402683 Kopman Sep 1983 A
4653476 Bonnet Mar 1987 A
4863430 Klyce et al. Sep 1989 A
4863438 Gauderer et al. Sep 1989 A
5073169 Raiken Dec 1991 A
5082005 Kaldany Jan 1992 A
5159921 Hoover Nov 1992 A
5176697 Hasson et al. Jan 1993 A
5183471 Wilk Feb 1993 A
5192301 Kamiya et al. Mar 1993 A
5242409 Buelna Sep 1993 A
5242415 Kantrowitz et al. Sep 1993 A
5257973 Villasuso Nov 1993 A
5257975 Foshee Nov 1993 A
5269772 Wilk Dec 1993 A
5312391 Wilk May 1994 A
5330486 Wilk Jul 1994 A
5334143 Carroll Aug 1994 A
5345927 Bonutti Sep 1994 A
5366478 Brinkerhoff et al. Nov 1994 A
5375588 Yoon Dec 1994 A
5391156 Hildwein et al. Feb 1995 A
5395367 Wilk Mar 1995 A
5437683 Neumann et al. Aug 1995 A
5460170 Hammerslag Oct 1995 A
5480410 Cuschieri et al. Jan 1996 A
5490843 Hildwein et al. Feb 1996 A
5507758 Thomason et al. Apr 1996 A
5511564 Wilk Apr 1996 A
5514133 Golub et al. May 1996 A
5514153 Bonutti May 1996 A
5522791 Leyva Jun 1996 A
5524644 Crook Jun 1996 A
5540648 Yoon Jul 1996 A
5545179 Williamson, IV Aug 1996 A
5601581 Fogarty et al. Feb 1997 A
5634911 Hermann et al. Jun 1997 A
5634937 Mollenauer et al. Jun 1997 A
5649550 Crook Jul 1997 A
5651771 Tangherlini et al. Jul 1997 A
5653705 de la Torre et al. Aug 1997 A
5672168 de la Torre et al. Sep 1997 A
5683378 Christy Nov 1997 A
5685857 Negus et al. Nov 1997 A
5713858 Heruth et al. Feb 1998 A
5713869 Morejon Feb 1998 A
5728103 Picha et al. Mar 1998 A
5730748 Fogarty et al. Mar 1998 A
5735791 Alexander, Jr. et al. Apr 1998 A
5741298 MacLeod Apr 1998 A
5782817 Franzel et al. Jul 1998 A
5795290 Bridges Aug 1998 A
5803921 Bonadio Sep 1998 A
5810712 Dunn Sep 1998 A
5813409 Leahy et al. Sep 1998 A
5830191 Hildwein et al. Nov 1998 A
5836871 Wallace et al. Nov 1998 A
5842971 Yoon Dec 1998 A
5848992 Hart et al. Dec 1998 A
5853417 Fogarty et al. Dec 1998 A
5857461 Levitsky et al. Jan 1999 A
5865817 Moenning et al. Feb 1999 A
5871474 Hermann et al. Feb 1999 A
5876413 Fogarty et al. Mar 1999 A
5894843 Benetti et al. Apr 1999 A
5899208 Bonadio May 1999 A
5899913 Fogarty et al. May 1999 A
5904703 Gilson May 1999 A
5906577 Beane et al. May 1999 A
5916198 Dillow Jun 1999 A
5941898 Moenning et al. Aug 1999 A
5951588 Moenning Sep 1999 A
5957913 de la Torre et al. Sep 1999 A
5964781 Mollenauer et al. Oct 1999 A
5976174 Ruiz Nov 1999 A
5997515 de la Torre et al. Dec 1999 A
6017355 Hessel et al. Jan 2000 A
6018094 Fox Jan 2000 A
6024736 de la Torre et al. Feb 2000 A
6033426 Kaji Mar 2000 A
6033428 Sardella Mar 2000 A
6042573 Lucey Mar 2000 A
6048309 Flom et al. Apr 2000 A
6059816 Moenning May 2000 A
6068639 Fogarty et al. May 2000 A
6077288 Shimomura et al. Jun 2000 A
6086603 Termin et al. Jul 2000 A
6099506 Macoviak et al. Aug 2000 A
6110154 Shimomura et al. Aug 2000 A
6142936 Beane et al. Nov 2000 A
6183485 Thomason et al. Feb 2001 B1
6197002 Peterson Mar 2001 B1
6217555 Hart et al. Apr 2001 B1
6228063 Aboul-Hosn May 2001 B1
6238373 de la Torre et al. May 2001 B1
6241768 Agarwal et al. Jun 2001 B1
6254534 Butler et al. Jul 2001 B1
6264604 Kieturakis et al. Jul 2001 B1
6315770 de la Torre et al. Nov 2001 B1
6319246 de la Torre et al. Nov 2001 B1
6371968 Kogasaka et al. Apr 2002 B1
6382211 Crook May 2002 B1
6423036 Van Huizen Jul 2002 B1
6440061 Wenner et al. Aug 2002 B1
6440063 Beane et al. Aug 2002 B1
6443957 Addis Sep 2002 B1
6447489 Peterson Sep 2002 B1
6450983 Rambo Sep 2002 B1
6454783 Piskun Sep 2002 B1
6464686 O'Hara et al. Oct 2002 B1
6468292 Mollenauer et al. Oct 2002 B1
6488620 Segermark et al. Dec 2002 B1
6488692 Spence et al. Dec 2002 B1
6527787 Fogarty et al. Mar 2003 B1
6551270 Bimbo et al. Apr 2003 B1
6558371 Dorn May 2003 B2
6578577 Bonadio et al. Jun 2003 B2
6582364 Butler et al. Jun 2003 B2
6589167 Shimomura et al. Jul 2003 B1
6613952 Rambo Sep 2003 B2
6623426 Bonadio et al. Sep 2003 B2
6669674 Macoviak et al. Dec 2003 B1
6676639 Ternstrom Jan 2004 B1
6706050 Giannadakis Mar 2004 B1
6723044 Pulford et al. Apr 2004 B2
6723088 Gaskill, III et al. Apr 2004 B2
6725080 Melkent et al. Apr 2004 B2
6800084 Davison et al. Oct 2004 B2
6814078 Crook Nov 2004 B2
6840946 Fogarty et al. Jan 2005 B2
6840951 de la Torre et al. Jan 2005 B2
6846287 Bonadio et al. Jan 2005 B2
6863674 Kasahara et al. Mar 2005 B2
6878110 Yang et al. Apr 2005 B2
6890295 Michels et al. May 2005 B2
6913609 Yencho et al. Jul 2005 B2
6916310 Sommerich Jul 2005 B2
6916331 Mollenauer et al. Jul 2005 B2
6929637 Gonzalez et al. Aug 2005 B2
6939296 Ewers et al. Sep 2005 B2
6945932 Caldwell et al. Sep 2005 B1
6958037 Ewers et al. Oct 2005 B2
6972026 Caldwell et al. Dec 2005 B1
6991602 Nakazawa et al. Jan 2006 B2
6997909 Goldberg Feb 2006 B2
7001397 Davison et al. Feb 2006 B2
7008377 Beane et al. Mar 2006 B2
7014628 Bousquet Mar 2006 B2
7033319 Pulford et al. Apr 2006 B2
7052454 Taylor May 2006 B2
7056321 Pagliuca et al. Jun 2006 B2
7077852 Fogarty et al. Jul 2006 B2
7081089 Bonadio et al. Jul 2006 B2
7100614 Stevens et al. Sep 2006 B2
7101353 Lui et al. Sep 2006 B2
7153261 Wenchell Dec 2006 B2
7163510 Kahle et al. Jan 2007 B2
7192436 Sing et al. Mar 2007 B2
7195590 Butler et al. Mar 2007 B2
7214185 Rosney et al. May 2007 B1
7217277 Parihar et al. May 2007 B2
7223257 Shubayev et al. May 2007 B2
7223278 Davison et al. May 2007 B2
7235084 Skakoon et al. Jun 2007 B2
7238154 Ewers et al. Jul 2007 B2
7276075 Callas et al. Oct 2007 B1
7294103 Bertolero et al. Nov 2007 B2
7300399 Bonadio et al. Nov 2007 B2
7316699 McFarlane Jan 2008 B2
7331940 Sommerich Feb 2008 B2
7344547 Piskun Mar 2008 B2
7377898 Ewers et al. May 2008 B2
7393322 Wenchell Jul 2008 B2
7412977 Fields et al. Aug 2008 B2
7445597 Butler et al. Nov 2008 B2
7473221 Ewers et al. Jan 2009 B2
7540839 Butler et al. Jun 2009 B2
7559893 Bonadio et al. Jul 2009 B2
7645232 Shluzas Jan 2010 B2
7650887 Nguyen et al. Jan 2010 B2
7704207 Albrecht et al. Apr 2010 B2
7717847 Smith May 2010 B2
7727146 Albrecht et al. Jun 2010 B2
7736306 Brustad et al. Jun 2010 B2
7753901 Piskun et al. Jul 2010 B2
7798898 Luciano, Jr. et al. Sep 2010 B2
8317690 Ransden et al. Nov 2012 B2
8932213 Okoniewski Jan 2015 B2
9744317 Okoniewski Aug 2017 B2
20010037053 Bonadio et al. Nov 2001 A1
20020038077 de la Torre et al. Mar 2002 A1
20020183594 Beane et al. Dec 2002 A1
20030014076 Mollenauer et al. Jan 2003 A1
20030028179 Piskun Feb 2003 A1
20030135091 Nakazawa et al. Jul 2003 A1
20030171713 McFarlane Sep 2003 A1
20030236549 Bonadio et al. Dec 2003 A1
20040015185 Ewers Jan 2004 A1
20040049099 Ewers et al. Mar 2004 A1
20040092795 Bonadio et al. May 2004 A1
20040092796 Butler et al. May 2004 A1
20040111061 Curran Jun 2004 A1
20040138529 Wiltshire et al. Jul 2004 A1
20040167543 Mazzocchi et al. Aug 2004 A1
20040267096 Caldwell et al. Dec 2004 A1
20050020884 Hart et al. Jan 2005 A1
20050043592 Boyd et al. Feb 2005 A1
20050096695 Olich May 2005 A1
20050148823 Vaugh et al. Jul 2005 A1
20050192483 Bonadio et al. Sep 2005 A1
20050203346 Bonadio et al. Sep 2005 A1
20050241647 Nguyen et al. Nov 2005 A1
20050288558 Ewers et al. Dec 2005 A1
20060020241 Piskun et al. Jan 2006 A1
20060084842 Hart et al. Apr 2006 A1
20060129165 Edoga et al. Jun 2006 A1
20060149306 Hart et al. Jul 2006 A1
20060161049 Beane et al. Jul 2006 A1
20060161050 Butler et al. Jul 2006 A1
20060229501 Jensen et al. Oct 2006 A1
20060241651 Wilk Oct 2006 A1
20060247498 Bonadio et al. Nov 2006 A1
20060247499 Butler et al. Nov 2006 A1
20060247500 Voegele et al. Nov 2006 A1
20060247516 Hess et al. Nov 2006 A1
20060247586 Voegele et al. Nov 2006 A1
20060247673 Voegele et al. Nov 2006 A1
20060247678 Weisenburgh et al. Nov 2006 A1
20060258899 Gill et al. Nov 2006 A1
20060270911 Voegele et al. Nov 2006 A1
20070093695 Bonadio et al. Apr 2007 A1
20070118175 Butler et al. May 2007 A1
20070149859 Albrecht et al. Jun 2007 A1
20070151566 Kahle et al. Jul 2007 A1
20070156023 Frasier et al. Jul 2007 A1
20070185387 Albrecht et al. Aug 2007 A1
20070203398 Bonadio et al. Aug 2007 A1
20070208312 Norton et al. Sep 2007 A1
20080027476 Piskun Jan 2008 A1
20080200767 Ewers et al. Aug 2008 A1
20080255519 Piskun et al. Oct 2008 A1
20090012477 Norton et al. Jan 2009 A1
20090036745 Bonadio et al. Feb 2009 A1
20090093752 Richard et al. Apr 2009 A1
20090131751 Spivey et al. May 2009 A1
20090221966 Richard Sep 2009 A1
20090270685 Moreno et al. Oct 2009 A1
20090326332 Carter Dec 2009 A1
20100081880 Widenhouse et al. Apr 2010 A1
20100185057 Stearns et al. Jul 2010 A1
20100228091 Widenhouse et al. Sep 2010 A1
20100228092 Ortiz et al. Sep 2010 A1
20100228094 Ortiz et al. Sep 2010 A1
20100240960 Richard Sep 2010 A1
20100249526 Shelton, IV et al. Sep 2010 A1
20110015491 Ravikumar et al. Jan 2011 A1
20110082341 Kleyman et al. Apr 2011 A1
20110082343 Okoniewski Apr 2011 A1
20110190590 Wingardner, III et al. Aug 2011 A1
Foreign Referenced Citations (20)
Number Date Country
0807416 Nov 1997 EP
0950376 Oct 1999 EP
1312318 May 2003 EP
1774918 Apr 2007 EP
2044889 Apr 2009 EP
93114801 Aug 1993 WO
9404067 Mar 1994 WO
9636283 Nov 1996 WO
9733520 Sep 1997 WO
9742889 Nov 1997 WO
9916368 Apr 1999 WO
0032120 Jun 2000 WO
200149363 Jul 2001 WO
200207611 Jan 2002 WO
2006100658 Sep 2006 WO
2008015566 Feb 2008 WO
2008042005 Apr 2008 WO
2008093313 Aug 2008 WO
2008103151 Aug 2008 WO
20080121294 Oct 2008 WO
Non-Patent Literature Citations (5)
Entry
European Search Report for corresponding EP 10251693 dated Feb. 22, 2011.
Extended European Search Report corresponding to counterpart Int'l Appln. No. EP 11 18 8921.8, dated Dec. 28, 2011.
European Office Action corresponding to counterpart Int'l Appln. No. EP 11 18 8921.8, dated Feb. 25, 2016.
Examination Report for European Patent Appln. No. 11188921.8 dated Apr. 8, 2015.
Canadian Office Action issued in corresponding Canadian Application No. 2,716,060 dated Jun. 16, 2016.
Related Publications (1)
Number Date Country
20170340842 A1 Nov 2017 US
Provisional Applications (1)
Number Date Country
61247654 Oct 2009 US
Continuations (5)
Number Date Country
Parent 14573673 Dec 2014 US
Child 15679732 US
Parent 14248520 Apr 2014 US
Child 14573673 US
Parent 14248534 Apr 2014 US
Child 14248520 US
Parent 13891717 May 2013 US
Child 14248534 US
Parent 12887847 Sep 2010 US
Child 13891717 US